China’s Ascletis Shares Surge on Oral Weight-Loss Drug Data

Ascletis Pharma Shares Surge on Drug Results

Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile.

Key Details

• The positive movement followed the release of promising mid-stage trial results for the company’s oral weight-loss treatment.

Image: Road Trip with Raj / Unsplash
Source: Bloomberg